Icagen Inc:企業の戦略的SWOT分析

GlobalDataが発行した調査報告書(DATA904C2736)
◆英語タイトル:Icagen Inc - Strategic SWOT Analysis Review
◆商品コード:DATA904C2736
◆発行会社(リサーチ会社):GlobalData
◆発行日:2018年8月
◆ページ数:26
◆レポート形式:英語 / PDF
◆納品方法:Eメール
◆調査対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD125 ⇒換算¥13,500見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD250 ⇒換算¥27,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥40,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。GlobalData社の概要及び新刊レポートはこちらでご確認いただけます。

【レポートの概要】

Icagen Inc – Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services.
This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.

Scope

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – GlobalData’s summarization of the company’s business strategy.
- SWOT analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list of key locations and subsidiaries of the company, including contact details.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.

Highlights

Icagen Inc (Icagen) (formerly known as XRpro Sciences, Inc.) is a biopharmaceutical company which develops drug candidates to unmet medical needs. The company discovers drug for clinical stage across multiple therapeutics and ion class channel classes. The company provides technologies including manual and automated electrophysiology, high throughput fluorescence and radiotracer flux assays. It offers screening services to pharmaceutical sector, including the use of proprietary x-ray fluorescence technology which is marketed as XRpro. It also delivers contract research services such as ion channel and transporter screening, assay development, cell line generation and custom assay services. The company has collaborations with Pfizer, Inc. Icagen is headquartered at Durham in North Carolina, the US.

Icagen Inc Key Recent Developments

May 01,2018: Icagen Receives Award from the Cystic Fibrosis Foundation to Discover Transformative Therapies to Treat Cystic Fibrosis
May 24,2017: Icagen to Showcase its Integrated Drug Discovery Platform at BIO International
Jan 30,2017: Icagen announces distribution agreement with On Target for advancing early drug discovery in Japanese market

Reasons to Buy

- Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.
- Identify potential customers and suppliers with this report’s analysis of the company’s business structure, operations, major products and services and business strategy.
- Understand and respond to your competitors’ business structure and strategies with GlobalData’s detailed SWOT analysis. In this, the company’s core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.
- Examine potential investment and acquisition targets with this report’s detailed insight into the company’s strategic, business and operational performance.

Note: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Section 1 – About the Company 5
Icagen Inc – Key Facts 5
Icagen Inc – Key Employees 6
Icagen Inc – Key Employee Biographies 7
Icagen Inc – Major Products and Services 8
Icagen Inc – History 9
Icagen Inc – Company Statement 10
Icagen Inc – Locations And Subsidiaries 12
Head Office 12
Section 2 – Company Analysis 13
Company Overview 13
Icagen Inc – Business Description 14
Icagen Inc – SWOT Analysis 15
SWOT Analysis – Overview 15
Icagen Inc – Strengths 15
Icagen Inc – Weaknesses 16
Icagen Inc – Opportunities 17
Icagen Inc – Threats 18
Icagen Inc – Key Competitors 19
Section 3 – Company’s Lifesciences Financial Deals and Alliances 20
Icagen Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 20
Icagen Inc, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018 21
Icagen Inc, Recent Deals Summary 22
Section 4 – Company’s Recent Developments 23
May 01, 2018: Icagen Receives Award from the Cystic Fibrosis Foundation to Discover Transformative Therapies to Treat Cystic Fibrosis 23
May 24, 2017: Icagen to Showcase its Integrated Drug Discovery Platform at BIO International 24
Jan 30, 2017: Icagen announces distribution agreement with On Target for advancing early drug discovery in Japanese market 25
Section 5 – Appendix 26
Methodology 26
About GlobalData 26
Contact Us 26
Disclaimer 26

List of Tables
Icagen Inc, Key Facts 5
Icagen Inc, Key Employees 6
Icagen Inc, Key Employee Biographies 7
Icagen Inc, Major Products and Services 8
Icagen Inc, History 9
Icagen Inc, Key Competitors 19
Icagen Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 20
Icagen Inc, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018 21
Icagen Inc, Recent Deals Summary 22

List of Figures
Icagen Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 20
Icagen Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 21

【免責事項】
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ Icagen Inc:企業の戦略的SWOT分析(Icagen Inc - Strategic SWOT Analysis Review)]についてメールでお問い合わせはこちらでお願いします。

◆H&Iグローバルリサーチのお客様(例)◆